Introduction
Obesity (MIM 601665) is a major risk factor for several clinical conditions, including diabetes, hypertension, coronary heart disease, lipid disorders, cancer and osteoarthrosis. While it seems obvious that the fundamental cause of weight gain is energy intake that persistently exceeds energy expenditure, 1 the factors that lead to this energy imbalance are not equally obvious. Genetic contribution to obesity as estimated by heritability of obesity-related phenotypes varies from 30 to 70% in most studies. 2 Identifying the specific genes or quantitative trait loci (QTL) that are linked to obesity is a challenge that is currently under intense investigation in many centers worldwide. Although several genome-wide scans for obesity phenotypes have been conducted in the last 5 y, 3 only one has been carried out among Africans living in Africa. In that study, Adeyemo et al 4 found significant evidence of linkage of body mass index (BMI) to QTLs on chromosomes 7 (at 50 cM) and 11 (at 101 cM). Given the paucity of data on genetic determinants of obesity in sub-Saharan Africa, we undertook a genome scan for QTLs linked to obesity phenotypes among participants in the Africa America Diabetes Mellitus (AADM) study. 5 
Methods

Subjects
Participants included in these analyses were enrolled in the AADM Study as described in detail by Rotimi et al. 5 The protocol was approved by the institutional review board (IRB) of each institution and written informed consent was obtained from all participants. The AADM study enrolled affected sib pairs (ASP) with type 2 diabetes (T2DM) and unaffected spouse controls. Parents were not enrolled neither were other family members. Participants were enrolled from three centers in Nigeria (Enugu, Ibadan and Lagos) and two centers in Ghana (Kumasi and Accra 
Measurements
A clinic examination was conducted that included a medical history, anthropometric measurements and blood sampling. Weight was measured on an electronic scale to the nearest 0.1 kg with the participant dressed in light clothing, and height was measured with a stadiometer to the nearest 0.1 cm. Body composition was estimated using bioelectric impedance analysis (BIA) as described in detail elsewhere. 7 A tetrapolar placement of electrodes was used, with current electrodes placed on the dorsal surfaces of the right hand and foot at the distal metacarpals and metatarsals, respectively, and the detector electrodes placed at the pisiform prominence of the right wrist and between the medial and lateral malleoli at the right ankle. Participants were measured with arms away from the torso at 451 and legs apart by about 12 inches; resistance was recorded in ohms. Impedance was calculated as height in cm divided by adjusted resistance. Fat-free mass (FFM) was calculated as TBW in kg divided by hydration constants. Fat mass (FM) was calculated as body weight in kg minus FFM. Calculations were carried out using validated population-specific equations 7 The three obesity phenotypes measured in this study, while highly correlated, differ from each other. BMI captures information on both body fat and nonfat tissue while FM is a measure of the absolute amount of body fat. PBF (percent body fat) is body fat relative to body weight and therefore corrects for the fact that a given amount of body fat will represent different proportions of body weight in each individual.
Genotyping
Genotyping was carried out at the Center for Inherited Disease Research (CIDR). The current CIDR marker set is composed primarily of trinucleotide and tetranucleotide repeats and consists of 392 primer pairs with average spacing of 8.9 cM throughout the genome. There are no gaps in the map larger than 18 cM. The average marker heterozygosity is 0.76. Approximately 10% of the marker loci are different between the current CIDR marker set and the Marshfield Genetics screening set version 8. Almost all reverse primer sequences have been modified from the version 8 sequences in order to reduce ' þ A' artifacts. The resulting PCR products are sized using a capillary sequencing platform. Data for the markers are generated with 218 PCR reactions (41 triplex reactions, 92 duplex reactions and 85 single reactions).
Primer pairs of the same dye color within a panel are PCR multiplexed together when possible. The markers are organized into 50 panels (eight-fold multiplexing postamplification). Each primer pair has undergone extensive optimization to improve performance and reliability. For this study, 390 short tandem repeat markers were genotyped for an average sex-equal distance of 9 cM and with no gaps greater than 18 cM. Extensive quality checks were carried out to verify consistency of marker genotyping and stated pedigree relationships. We used all 390 markers to check pedigree errors by means of the RELTEST program in SAGE 4.0. 8 Then, PEDCHECK 9 was used to check for Mendelian inconsistencies. The errors identified in PED-CHECK were assumed to have occurred in the genotyping process and the associated markers were set to missing among the appropriate pedigree. Hardy-Weinberg equilibrium at each locus was assessed by the w 2 test. 10 
Statistical analysis
Descriptive statistics were calculated using SAS version 8.2.
(The SAS Institute, Cary, NC, USA). Linkage analysis of obesity phenotypes was carried out using the multipoint variance components approach in the GENEHUNTER 2 program. 11 The expected genetic covariance between relatives was specified as a function of their identity-by-descent (IBD) relationship at a marker locus. The IBD probabilities were estimated from all available genotyped markers. The likelihood ratio test was applied to test the null hypothesis of no additive genetic variance due to a quantitative trait locus (QTL). Both siblings and half-siblings were included in the analysis. Gender, age, and age 2 were incorporated as covariates and their effects were simultaneously estimated by the maximum likelihood method. In order to assess the genome-wide significance of our LOD scores, gene-dropping simulations were carried using MERLIN. 12 Marker data were simulated under the null hypothesis of no linkage while retaining the same pedigree structures, maps, marker allele frequencies and missing data patterns. In total, 10 000 simulations were conducted for each phenotype. The probability of observing a specific nominal LOD score was Table 2 and Figure 1 . In all, three regions showed significant or suggestive linkage to at least one of the three obesity-related phenotypes.
The areas of linkage for the three phenotypes showed significant clustering as shown in Figure 1 . All three phenotypes (BMI, FM and PBF) had linkage peaks in the same regions in 2p13, 4q23 and 5q14; however, not all of the peaks reached the thresholds for significant or suggestive linkage.
Discussion
Our objective in the present study was to use the genome scan approach to identify QTLs influencing three obesityrelated phenotypes (ie, BMI, FM and PBF) in a sample of ASPs with type 2 diabetes enrolled from multiple centers in West Africa. The strongest linkage signals were found on chromosomes 2p, 4q and 5q with LOD scores ranging from 2.25 to 3.30. This study provides substantial evidence for linkage supporting QTLs previously reported to be linked to serum leptin and plasma adiponectin levels. The linkage region on chromosome 2 in this study (with the peak at 72.6 cM for PBF) overlaps with the region found to be linked to leptin in several studies [14] [15] [16] and with the region linked to plasma adiponectin by Comuzzie et al. 17 The linkage regions identified on chromosome 4 and 5 have not previously been reported as harboring QTLs influencing obesity phenotypes. Yet, the relatively strong linkage signals observed in this study suggest that these genomic regions may indeed contain QTLs influencing obesity traits. The linkage regions linked to LDL-cholesterol on chromosomes 10 (MLS 2.47) and 17 (MLS 2.33) in the NHLBI Family Heart Study 18 showed LOD scores of 1.01 and 1.44
(respectively) with BMI in this study (Table 2) , while a region on chromosome 20 linked to triglycerides in the A potential limitation of this study is that participants were required to have type 2 diabetes. In this regard, genomic regions in with significant linkage could represent susceptibility loci to type 2 diabetes. While this is indeed a possibility, the areas of significant linkage to diabetes in this study were quite different. 22 On the other hand, the above limitation may also represent a strength because ascertaining on diabetes status has definitely enriched the sample for higher BMI. Participants in the present study are, on average, about 5 BMI units heavier than the general population from which they were enrolled. 4, 15, 23 This enrichment for heaviness may have given this study greater power to detect obesity-related QTLs compared to randomly ascertained population samples since extreme phenotype values usually enhance the power to detect linkage. [24] [25] In conclusion, we have conducted a genome-wide linkage analysis to identify genomic regions linked to three obesity phenotypes (BMI, FM and PBF) in T2DM patients from West Africa. The obesity-related phenotype showing the strongest linkage evidence was PBF on chromosome 2 (LOD 3.30 at 72.6 cM, marker D2S739). Suggestive linkage to FM was found on chromosomes 2 (LOD 2.56 at 80.4 cM) and 5 (LOD 2.25 at 98 cM, marker D5S1725). The highest LOD score for BMI was 1.68 (chromosome 4, 113.8 cM). The areas of linkage for the three phenotypes showed some clustering as all three phenotypes were linked to the same regions of 2p13 and 5q14. Our study replicated linkage evidence for several regions previously reported in other populations. We intend to develop fine mapping strategies to further refine these linkage regions.
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